In this video on understanding your ambulatory glucose profile (AGP) report, pediatric endocrinologist, Dr. Amy Criego from the International Diabetes Center, uses real-...

If you just got a continuous glucose monitoring system, you may be wondering how to use it most effectively and how to understand your glucose data. Read our tips,...

In a study of children younger than seven, automated insulin delivery (AID) led to greater Time in Range, less Time above Range, and lower A1C levels.

Rybelsus, a GLP-1 agonist pill already approved in the US, received positive feedback from the European Medicines Agency (EMA) in January and was just approved on...

Diabetes and heart disease are closely connected. This article discusses heart disease, important numbers to know, and ways to improve your heart health

Highlights from The diaTribe Foundation and TCOYD panel discussion at ADA 2019

The diaTribe team covers the latest in diabetes technology from the 14th annual ATTD 2021 international conference (set virtually this year). Here are our top highlights...

The American Diabetes Association recommends SGLT-2 inhibitors or GLP-1 agonists for people with heart and kidney problems, the use of Time in Range in diabetes...

A summary of the landmark trials that show that careful blood glucose management can lower the risk of long-term health complications in people with type 1 or type 2...

My approach to time-in-range goals, five key tips to spend more time-in-range each day, and what’s still to come from experts…

We interviewed 15 experts about time-in-range goals for those wearing CGM. Here’s what they said…

How to recognize and treat severe hypoglycemia quickly – with emergency glucagon – and avoid a trip to the hospital.

MiniMed 670G becomes the first hybrid closed loop system officially approved for type 1 pediatric use; systems are available now. European approval also received for 7...

Read about Adam’s time-in-range over two years on Loop – +2 hours/day! – along with quality of life changes, better sleep, and the mealtime impact. Part 1 of a series on...

Mark Harmel, a Diabetes Care and Education Specialist, discusses the value of CGM reports, specifically the Glucose Management Indicator (GMI) and time in range (TIR)

How can you prevent or slow the progression of diabetic neuropathy with a continuous glucose monitor (CGM)? Research shows that higher Time in Range (TIR) is associated...

Time in Range, or TIR, is quickly becoming a metric everyone is talking about in diabetes. Whether you’re a TIR expert, or you just learned about this new metric, learn...

After joining The diaTribe Foundation earlier this year, Julie Heverly recently assumed the role of senior director of the Time in Range Coalition. Read how Julie, along...

A follow up to the MOBILE study, which demonstrated improvements in A1C and Time in Range for continuous glucose monitoring system (CGM) users with type 2 diabetes,...

Exciting new developments in diabetes research show that increasing your Time in Range can lower your risk of developing heart complications.